NCT03379662View on ClinicalTrials.gov

An Evaluation of Low Level Laser Light Therapy for Autistic Disorder

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

July 2, 2017

Primary Completion Date

October 28, 2017

Study Completion Date

November 28, 2017

Conditions
Autistic Disorder
Interventions
DEVICE

Erchonia HLS Laser

The Erchonia HLS Laser emits a 640 nm (nanometer) wavelength with a tolerance of ±10 nm from each of two 7.5 mw (milliwatt) laser diodes.

DEVICE

Placebo Laser

The Placebo Laser emit the same visible light output as the active HLS Laser but without therapeutic effect.

Trial Locations (1)

16470

Institute for Brain and Rehabilitation Sciences, Nazareth

Sponsors
All Listed Sponsors
lead

Erchonia Corporation

INDUSTRY